Viewing Study NCT03793361


Ignite Creation Date: 2025-12-24 @ 1:10 PM
Ignite Modification Date: 2026-02-25 @ 8:15 PM
Study NCT ID: NCT03793361
Status: COMPLETED
Last Update Posted: 2024-12-10
First Post: 2018-12-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Regorafenib as Maintenance Therapy
Sponsor: Centre Oscar Lambret
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module